AQR Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
1,148,794
-52,655
| -4% | -$472K | 0.01% | 962 |
|
|
2025
Q1 | $9.01M | Buy |
1,201,449
+362,175
| +43% | +$2.72M | 0.01% | 908 |
|
|
2024
Q4 | $6.31M | Buy |
839,274
+52,047
| +7% | +$391K | 0.01% | 1000 |
|
|
2024
Q3 | $5.98M | Buy |
787,227
+243,986
| +45% | +$1.85M | 0.01% | 976 |
|
|
2024
Q2 | $3.36M | Buy |
543,241
+85,871
| +19% | +$531K | 0.01% | 1223 |
|
|
2024
Q1 | $2.32M | Buy |
457,370
+83,426
| +22% | +$424K | ﹤0.01% | 1346 |
|
|
2023
Q4 | $2.24M | Buy |
373,944
+300,427
| +409% | +$1.8M | ﹤0.01% | 1293 |
|
|
2023
Q3 | $521K | Buy |
73,517
+35,429
| +93% | +$251K | ﹤0.01% | 1833 |
|
|
2023
Q2 | $268K | Sell |
38,088
-820
| -2% | -$5.77K | ﹤0.01% | 1982 |
|
|
2023
Q1 | $324K | Buy |
38,908
+13,916
| +56% | +$116K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $287K | Buy |
24,992
+2,432
| +11% | +$27.9K | ﹤0.01% | 1984 |
|
|
2022
Q3 | $284K | Sell |
22,560
-7,357
| -25% | -$92.6K | ﹤0.01% | 1959 |
|
|
2022
Q2 | $317K | Sell |
29,917
-26,762
| -47% | -$284K | ﹤0.01% | 1847 |
|
|
2022
Q1 | $922K | Sell |
56,679
-42,185
| -43% | -$686K | ﹤0.01% | 1585 |
|
|
2021
Q4 | $1.37M | Sell |
98,864
-31,209
| -24% | -$432K | ﹤0.01% | 1397 |
|
|
2021
Q3 | $1.87M | Buy |
130,073
+22,152
| +21% | +$318K | ﹤0.01% | 1183 |
|
|
2021
Q2 | $1.71M | Buy |
107,921
+46,535
| +76% | +$736K | ﹤0.01% | 1308 |
|
|
2021
Q1 | $624K | Sell |
61,386
-960
| -2% | -$9.76K | ﹤0.01% | 1752 |
|
|
2020
Q4 | $464K | Sell |
62,346
-41,431
| -40% | -$308K | ﹤0.01% | 1815 |
|
|
2020
Q3 | $356K | Sell |
103,777
-14,836
| -13% | -$50.9K | ﹤0.01% | 1852 |
|
|
2020
Q2 | $565K | Buy |
118,613
+97,744
| +468% | +$466K | ﹤0.01% | 1692 |
|
|
2020
Q1 | $42K | Sell |
20,869
-26,780
| -56% | -$53.9K | ﹤0.01% | 2008 |
|
|
2019
Q4 | $164K | Buy |
47,649
+21,392
| +81% | +$73.6K | ﹤0.01% | 2036 |
|
|
2019
Q3 | $75K | Sell |
26,257
-17,020
| -39% | -$48.6K | ﹤0.01% | 2091 |
|
|
2019
Q2 | $164K | Sell |
43,277
-3,593
| -8% | -$13.6K | ﹤0.01% | 1994 |
|
|
2019
Q1 | $382K | Buy |
46,870
+2,185
| +5% | +$17.8K | ﹤0.01% | 1886 |
|
|
2018
Q4 | $361K | Buy |
+44,685
| New | +$361K | ﹤0.01% | 1896 |
|
|
2018
Q2 | – | Sell |
-29,043
| Closed | -$139K | – | 2317 |
|
|
2018
Q1 | $139K | Sell |
29,043
-24,097
| -45% | -$115K | ﹤0.01% | 2186 |
|
|
2017
Q4 | $261K | Sell |
53,140
-12,979
| -20% | -$63.7K | ﹤0.01% | 2090 |
|
|
2017
Q3 | $346K | Buy |
66,119
+11,797
| +22% | +$61.7K | ﹤0.01% | 2042 |
|
|
2017
Q2 | $302K | Buy |
54,322
+12,571
| +30% | +$69.9K | ﹤0.01% | 2037 |
|
|
2017
Q1 | $351K | Buy |
+41,751
| New | +$351K | ﹤0.01% | 1982 |
|
|
2016
Q3 | – | Sell |
-97,873
| Closed | -$278K | – | 2252 |
|
|
2016
Q2 | $278K | Sell |
97,873
-26,741
| -21% | -$76K | ﹤0.01% | 2029 |
|
|
2016
Q1 | $353K | Buy |
124,614
+100,050
| +407% | +$283K | ﹤0.01% | 1949 |
|
|
2015
Q4 | $254K | Sell |
24,564
-29,252
| -54% | -$302K | ﹤0.01% | 2077 |
|
|
2015
Q3 | $614K | Buy |
53,816
+31,760
| +144% | +$362K | ﹤0.01% | 1649 |
|
|
2015
Q2 | $329K | Sell |
22,056
-206,579
| -90% | -$3.08M | ﹤0.01% | 1945 |
|
|
2015
Q1 | $2.06M | Sell |
228,635
-246,800
| -52% | -$2.23M | ﹤0.01% | 1092 |
|
|
2014
Q4 | $5.78M | Buy |
475,435
+132,373
| +39% | +$1.61M | 0.01% | 866 |
|
|
2014
Q3 | $3.36M | Buy |
343,062
+230,200
| +204% | +$2.25M | 0.01% | 1001 |
|
|
2014
Q2 | $1.44M | Buy |
112,862
+1,100
| +1% | +$14K | ﹤0.01% | 1454 |
|
|
2014
Q1 | $1.18M | Buy |
111,762
+16,500
| +17% | +$175K | ﹤0.01% | 1616 |
|
|
2013
Q4 | $724K | Buy |
+95,262
| New | +$724K | ﹤0.01% | 1876 |
|